Patrick de Boer ^UDM

Patrick de Boer, CEO at Aiosyn, is driven by developing new-generation digital health technologies that use artificial intelligence to provide actionable, data-driven insights for healthcare professionals. With a background in health sciences and management, de Boer co-founded ttopstart, a leading life sciences consulting company. Aiosyn, a spin-off from the Computational Pathology Group of Radboudumc, is using AI to develop precision pathology software, enhancing digital pathology workflows and improving histological assessments for diseases like breast cancer and chronic kidney disease.